Braveheart Investment Group plc Non Regulatory - PhaseFocus Update
16 Dezembro 2021 - 4:00AM
RNS Non-Regulatory
TIDMBRH
Braveheart Investment Group plc
16 December 2021
Reach - a non-regulatory announcement
16 December 2021
Braveheart Investment Group plc
("Braveheart" or the "Group")
Update re. PhaseFocus Holdings Limited
PhaseFocus has developed a series of patented computational
imaging techniques that have a wide range of applications including
live cell imaging, engineering metrology and electron microscopy.
The research work and testimonials from the Francis Crick
Institute, Huntsman Cancer Institute and universities of St Georges
(London) and York give an insight to why Livecyte(TM) leads the
market in cell imaging
(https://phasefocus.com/resources/customer-testimonials).
Its distribution agreement with Swedish bio-convergence company
BICO Group AB is now providing an excellent platform for driving
sales growth across the EU and USA. BICO's CYTENA division is
promoting Livecyte(TM) very strongly in its markets,
https://www.cytena.com/livecyte/ with considerable success, and
this month, PhaseFocus will ship three Livecyte(TM) cell imaging
systems to CYTENA, destined for world leading research centres in
the EU and USA. Demonstrations to public health laboratories by
CYTENA are ongoing and the potential sales pipeline for 2022 is
growing.
Following the recent sale of a Livecyte(TM) cell imaging system
to St George's, University of London, PhaseFocus' UK distributor,
Lablogic is targeting sales of Livecyte(TM) cell imaging systems to
other UK's university-based researchers. A video of the
Livecyte(TM) system working at St Georges University in London can
be viewed here
https://lablogic.com/life-sciences/instruments/phasefocus-livecyte.
Additionally, PhaseFocus' distributors in China, Japan,
Australia and Italy are also experiencing good levels of
enquiry.
PhaseFocus is planning to expand its Nottingham production
facility in Q1 2022 to meet this anticipated demand.
For further
information:
Braveheart Investment Group plc Tel: 01738 587555
Viv Hallam, Executive Director
Allenby Capital Limited (Nominated Adviser Tel: 020 3328 5656
and Joint Broker)
David Worlidge / James Hornigold
Peterhouse Capital Limited (Joint Broker) Tel: 020 7469 0936
Heena Karani / Lucy Williams
About Reach announcements
This is a Reach announcement. Reach is an investor communication
service aimed at assisting listed and unlisted (including AIM
quoted) companies to distribute media only / non-regulatory news
releases into the public domain. Information required to be
notified under the AIM Rules for Companies, Market Abuse Regulation
or other regulation would be disseminated as an RNS regulatory
announcement and not on Reach.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAFLFFRFLLELIL
(END) Dow Jones Newswires
December 16, 2021 02:00 ET (07:00 GMT)
Braveheart Investment (LSE:BRH)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Braveheart Investment (LSE:BRH)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024